Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Parathyroid Neoplasms 1Neovascularization, Pathologic 1Hyperparathyroidism, Primary 1Carcinoma, Renal Cell 1

Interventions

Carboplatin 127Cisplatin 125Drug Therapy 117Bevacizumab 102Oxaliplatin 99Capecitabine 99Radiotherapy 97Gemcitabine 87tislelizumab 86Paclitaxel 86Cyclophosphamide 86Specimen Handling 80pembrolizumab 76toripalimab 68Magnetic Resonance Spectroscopy 65Fluorouracil 63Injections 62sintilimab 58Surgical Procedures, Operative 58anlotinib 53Docetaxel 52130-nm albumin-bound paclitaxel 50fludarabine 47Standard of Care 46Pemetrexed 45Immune Checkpoint Inhibitors 45Blood Specimen Collection 43Biopsy 43venetoclax 42Leucovorin 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Rubidium-82 × Clear all
NCT07346404 2026-01-16

RUBIKID

Assistance Publique - Hôpitaux de Paris

Phase 2 Not yet recruiting
50 enrolled
Genitourinary

Carcinoma, Renal Cell, Neovascularization, Pathologic

NCT07099404 2025-08-22

PARAGON

Montreal Heart Institute

Not yet recruiting
20 enrolled
Head & Neck

Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡